Evidence map›Paper›PMID 32524465›Full record

ArticleNatural products and bioprospecting2020

Acute and Sub-chronic Toxicity of Indole Alkaloids Extract from Leaves of Alstonia scholaris (L.) R. Br. in Beagle Dogs.

Yun-Li Zhao, Min Su, Jian-Hua Shang, Xia Wang, Guang-Lei Bao, Jia Ma, Qing-Di Sun, Fang Yuan, Jing-Kun Wang, Xiao-Dong Luo

Open access · diamondAbstract read
In one paragraph

Article in Natural products and bioprospecting, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 14 citations in OpenAlex.

  1. The safety and tolerability of alkaloids fromPharmaceutical biology · 2021
    Trial
  2. Article
  3. Article
  4. Indole: The After Next Scaffold of Antiplasmodial Agents?Drug design, development and therapy · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Yun-Li ZhaoState Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming, 650201, People's Republic of China.
Min SuYunnan Institute of Medical Material, Kunming, 650111, People's Republic of China.
Jian-Hua ShangYunnan Institute of Medical Material, Kunming, 650111, People's Republic of China.
Xia WangYunnan Institute of Medical Material, Kunming, 650111, People's Republic of China.
Guang-Lei BaoYunnan Institute of Medical Material, Kunming, 650111, People's Republic of China.
Jia MaYunnan Institute of Medical Material, Kunming, 650111, People's Republic of China.
Qing-Di SunJiangsu Nhwa Pharmaceutical Co., Ltd, Xuzhou, 221009, People's Republic of China.
Fang YuanYunnan Institute of Medical Material, Kunming, 650111, People's Republic of China.
Jing-Kun WangYunnan Institute of Medical Material, Kunming, 650111, People's Republic of China. wjkyimm@163.com.
Xiao-Dong LuoState Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming, 650201, People's Republic of China. xdluo@mail.kib.ac.cn.ORCID http://orcid.org/0000-0002-6768-5679
Kunming Institute of Botany · CNJiangsu Nhwa Pharmaceutical (China) · CNKunming Medical University · CNYunnan University · CN

Funding

Applied Basic Research Foundation of Yunnan Province 2019FB116National Key Research and Development Program of China 2017YFC1704007Yunnan Major Science and Technology Project 2019FY003004Yunnan Major Science and Technology Project 2019ZF003
6 · The paper itself

Abstract

Alstonia scholaris (L.) R. Br., an evergreen tropical plant rich in indole alkaloids with significant physiological activity, is traditionally used to treat respiratory diseases in China. This study was conducted to establish the toxicity profile of the alkaloid extract (TA) of A. scholaris leaves in non-rodents. After oral administration of a single dose (4 g/kg.bw), a number of transient symptoms, such as unsteady gait, drooling, emesis, and reddening of peri-oral mucosa, were observed, but no treatment-related mortality. A sub-chronic toxicity study with a range of doses of TA (20, 60 and 120 mg/kg.bw) was conducted for a 13-week treatment period, followed by 4-week recovery observation. Except for emesis and drooling in majority of animals in 120 mg/kg.bw treatment group, no clinical changes were observed in TA-treated animals. Data from electrocardiography, bone marrow, urine, fecal, hematology and clinical chemistry analyses were comparable between TA-treated and control animals. No significant differences in the relative organ weights and histopathological characteristics were evident between the TA-treated and control groups. Accordingly, the non-observed-adverse-effect-level (NOAEL) of TA was established as 120 mg/kg.bw. Our results add further knowledge to the safety database for indole alkaloid extracts from A. scholaris with potential utility as novel drug candidates.

Indexed as

Acute toxicityAlstonia scholarisBeagle dogIndole alkaloidsNon-observed-adverse-effect-levelSub-chronic toxicity

Identifiers

PMID32524465
PMCPMC7367998
OpenAlexW3033110393

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.